Your browser doesn't support javascript.
loading
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma.
Chakraborty, Rajshekhar; Cheruvalath, Heloise; Patwari, Anannya; Szabo, Aniko; Schinke, Carolina; Dhakal, Binod; Lentzsch, Suzanne; D'Souza, Anita; Mohyuddin, Ghulam Rehman; Julian, Kelley; Midha, Shonali; Costello, Patrick; Kaiser, Martin; Hing, Melissa Ng Liet; Harrison, Simon J; Cliff, Edward R Scheffer; Mohan, Meera.
Afiliación
  • Chakraborty R; Columbia University Irving Medical Center, New York, NY, USA. rc3360@cumc.columbia.edu.
  • Cheruvalath H; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Patwari A; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Szabo A; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Schinke C; University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Dhakal B; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Lentzsch S; Columbia University Irving Medical Center, New York, NY, USA.
  • D'Souza A; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Mohyuddin GR; Huntsman Cancer Center, University of Utah, Salt Lake City, UT, USA.
  • Julian K; Huntsman Cancer Center, University of Utah, Salt Lake City, UT, USA.
  • Midha S; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Costello P; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Kaiser M; The Institute of Cancer Research, London, UK.
  • Hing MNL; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Harrison SJ; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Cliff ERS; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Mohan M; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
Blood Cancer J ; 14(1): 137, 2024 Aug 12.
Article en En | MEDLINE | ID: mdl-39134535

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Mieloma Múltiple Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Mieloma Múltiple Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos